Korb Donald R, Scaffidi Robert C, Greiner Jack V, Kenyon Kenneth R, Herman John P, Blackie Caroline A, Glonek Thomas, Case Courtney L, Finnemore Victor M, Douglass Teresa
Korb Associates, Boston, MA 02116, USA.
Optom Vis Sci. 2005 Jul;82(7):594-601. doi: 10.1097/01.opx.0000171818.01353.8c.
Because the lipid layer of the tear film is recognized as a critical component in dry eye disease, this study was designed to determine if a single eye drop of either Soothe or Systane produces a significant increase in lipid layer thickness (LLT) for subjects reporting symptoms indicative of dry eyes.
A double-blind, internally paired study was performed. A custom-built lipid layer interferometer, enabling characterization of lipid layer interference patterns, was used to quantify baseline LLT (OU) of eligible subjects. Inclusion criteria included: 1) presence of dry eye symptoms and 2) baseline LLT < or =75 nm. Subjects (n = 40) received a single eye drop of Soothe in one eye and a single eye drop of Systane in the contralateral eye. After the instillation of each test drop, LLT was reanalyzed for all subjects.
The mean +/- standard error baseline LLT pre-eye drop instillation was 60.0 +/- 1.8 nm for eyes treated with Soothe and 61.5 +/- 1.8 nm for eyes treated with Systane. These means were not significantly different (p > 0.5). The mean LLT for eyes treated with Soothe increased to 124.4 +/- 4.9 nm (p < 0.0001). The mean LLT for eyes treated with Systane increased to 71.3 +/- 2.6 nm (p < 0.0001). The LLT increase from Soothe was significantly greater than that from Systane (p < 0.0001).
In subjects with symptoms indicative of dry eye states and LLT < or =75 nm, one eye drop of Soothe more than doubled LLT, a 107% mean increase, whereas Systane increased LLT by 16%.
由于泪膜脂质层被认为是干眼症的关键组成部分,本研究旨在确定对于报告有干眼症状的受试者,单滴舒润(Soothe)或思然(Systane)眼药水是否会使脂质层厚度(LLT)显著增加。
进行了一项双盲、自身配对研究。使用定制的脂质层干涉仪来量化符合条件的受试者的基线LLT(双眼),该干涉仪能够对脂质层干涉图样进行表征。纳入标准包括:1)存在干眼症状;2)基线LLT≤75纳米。受试者(n = 40)一只眼睛滴入单滴舒润眼药水,对侧眼睛滴入单滴思然眼药水。在滴入每种测试眼药水后,对所有受试者重新分析LLT。
滴入眼药水前,舒润眼药水治疗的眼睛的平均±标准误基线LLT为60.0±1.8纳米,思然眼药水治疗的眼睛为61.5±1.8纳米。这些平均值无显著差异(p>0.5)。舒润眼药水治疗的眼睛的平均LLT增加到124.4±4.9纳米(p<0.0001)。思然眼药水治疗的眼睛的平均LLT增加到71.3±2.6纳米(p<0.0001)。舒润眼药水导致的LLT增加显著大于思然眼药水(p<0.0001)。
对于有干眼症状且LLT≤75纳米的受试者,单滴舒润眼药水使LLT增加了一倍多,平均增加了107%,而思然眼药水使LLT增加了16%。